fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

Syrian Newborn Baby Boy Flown to Israel for Emergency Heart Surgery

congenital heart defect surgery at Sheba Medical Center in Israel
A 10-day-old infant was brought from Cyprus to Sheba Medical Center for an emergency procedure to correct a congenital heart defect.

Last week, a Syrian baby boy was flown from Cyprus to Israel, where life-saving heart surgery was performed at Sheba Medical Center. After an emergency operation to correct his congenital heart defect, the newborn was moved to a recovery ward. Presently, he is on a respirator and recuperating, according to an official Sheba representative.

The baby will require a few weeks to recover sufficiently for safe travel. Until then, the baby’s father will be staying with him in the hospital.

This surgery marks the first time that Sheba treated an emergency patient brought in from overseas since the start of the global coronavirus pandemic. Prior to the spread of COVID-19, these types of cases were common. In the past, many patients from countries that have diplomatic ties with Israel and from countries that are not allies, such as Iraq and Syria, have been provided with expert medical care in Israel.

Sammy Revel, Israel’s ambassador to Cyprus, said that bringing the boy to Sheba was an initiative that required intricate coordination with Cyprus’s health ministry and special approval from Jerusalem.

For five years, from 2013 to 2018, Israel sustained a program along the Syrian border to allow local residents who were affected by the civil war to enter Israel for medical treatment. In the summer of 2018, when Syrian dictator Bashar Assad assumed control of southern Syria, that program was officially ended.

Related
Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba and Vidac
Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness
While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More